← FDA Drug Approvals (Drugs@FDA)
CYLTEZO
BLA · Biologics License Application · Sponsor: BOEHRINGER INGELHEIM · Approved 2017-08-25
Drug application
- FDA Application #
BLA761058- Application type
- Biologics License Application
- Brand name
- CYLTEZO
- Generic name
- ADALIMUMAB-ADBM
- Active ingredients
- ADALIMUMAB-ADBM
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- BOEHRINGER INGELHEIM
- Manufacturer
- QUALLENT PHARMACEUTICALS HEALTH LLC
- First approval
- 2017-08-25
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown